Welcome to MarylandLifeScience.com
MarylandLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Maryland
Are you considering a move to Maryland? Relocating your business to
Maryland? Starting a company? Or just interested in Maryland?
This section will answer many of your questions regarding the life science industry in Maryland, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Barr receives approval for generic version of Razadyne(R) tablets Barr Pharmaceuticals announced that its subsidiary, Barr Laboratories, received final approval from the U.S. Food & Drug Administration (FDA) to manufacture and market a generic version of Ortho McNeil Janssen's Razadyne(R) (galantamine hydrobromide), 4 mg, 8 mg and 12 mg tablets.
Barr Pharmaceuticals, Inc. August 28, 2008
- Ortho-McNeil Neurologics to appeal patent ruling on RAZADYNE(R) Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, announced that it will appeal yesterday's decision by the U.S. District Court of Delaware, which ruled the patent for RAZADYNE(R) (galantamine hydrobromide) is invalid.
Johnson & Johnson August 28, 2008
- Barr announces favorable ruling in Razadyne(R) patent challenge Barr Pharmaceuticals announced that the U.S. District Court for the District of Delaware has ruled in favor of its subsidiary, Barr Laboratories, in the challenge of U.S. Patent No. 4,663,318 listed by Ortho McNeil Janssen in connection with Janssen's Razadyne(R), 4mg, 8mg and 12mg tablets.
Barr Pharmaceuticals, Inc. August 28, 2008
- The CYPHER(R) Stent outperforms the Taxus(R) Stent in people with diabetes In patients with diabetes, the CYPHER(R) Sirolimus-eluting Coronary Stent outperformed the Taxus(R) Stent with lower rates of in-segment restenosis, target lesion revascularization and major adverse events at nine months according to clinical data.
Johnson & Johnson August 28, 2008
- Monsanto and Evogene collaborate on yield and stress research Monsanto Company and Evogene have entered into a five-year research and development collaboration focused on identifying key plant genes related to yield, environmental stress and fertilizer utilization.
Monsanto Company August 28, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Maryland's BioHistory
Why is there a biotechnology industry in Maryland? Will the industry continue
to grow in Maryland? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Maryland BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Maryland.
More...
BioEvolution Posters
More...
Your Guide to Reporting Problems to FDA
Consumers play an important public health role by reporting to the Food and
Drug Administration (FDA) any adverse events (unexpected side effects) after
using a medical product, or other problems with any products that the agency
regulates.
Timely reporting allows the agency to take prompt action. There are a
number of ways you can report problems to the agency, depending on the type of
problem and product.
More...
BioFact
(1977) - Genentech becomes the first company founded specifically to apply recombinant DNA techniques for commercial purposes.
It's a Small World
|
| |
Plant Cells
| |
Science Quote
"It is a capital mistake to theorise before one has data. Insensibly one begins to twist facts to suit theories instead of theories to suit facts."
| - |
Sherlock Holmes, fictional creation of Arthur Conan Doyle, British physician and novelist
|
|
(1859-1930)
|
|
